A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjuctivitis and rhinoconjunctivitis-Reference-Cited by-同舟云学术

A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjuctivitis and rhinoconjunctivitis

Published:2003-03 Issue:3 Volume:25 Page:931-947
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Abelson Mark B,Turner Darell

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis;Abelson;Acta Ophthalmol Scand Suppl,1999

2. The effects of systemic medication on ocular allergic disease;Berdy;Acta Ophthalmol Scand Suppl,2000

3. Ocular allergic disorders and dry eye disease: Associations, diagnostic dilemmas, and management;Berdy;Acta Ophthalmol Scand Suppl,2000

4. Current and future topical treatments for ocular allergy;Abelson;Compr Ophthalmol Update,2000

5. Acute allergic conjunctivitis;Collum,2001

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based use of antihistamines for treatment of allergic conditions;Annals of Allergy, Asthma & Immunology;2023-10

2. Therapeutic Targets in Allergic Conjunctivitis;Pharmaceuticals;2022-04-28

3. Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis;Clinical and Translational Allergy;2021-03

4. Role of oxidative stress and vascular endothelial growth factor expression in pterygium pathogenesis and prevention of pterygium recurrence after surgical excision;International Ophthalmology;2020-06-06

5. A contemporary look at allergic conjunctivitis;Allergy, Asthma & Clinical Immunology;2020-01-21